Brief: Inhibikase Therapeutics To Present Phase 1/1B Clinical Data At The Upcoming Ad/Pd Alzheimer's & Parkinson's Diseases Conference
08/03/2022 13:29
March 8 (Reuters) - Inhibikase Therapeutics Inc IKT.O :
* INHIBIKASE THERAPEUTICS TO PRESENT PHASE 1/1B CLINICAL DATA AT THE
UPCOMING
AD/PD™ ALZHEIMER'S & PARKINSON'S DISEASES CONFERENCE
Source text for Eikon: ID:nPnbKRYwHa
Further company coverage: IKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share
Brief: Inhibikase Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Brief: Inhibikase Therapeutics Advancing IKT-001 To Global Phase 3 Study In Pulmonary Arterial Hypertension
Cardiopulmonary drugmaker Inhibikase Therapeutics' Q3 net loss widens
Inhibikase Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary